Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 394.92M | 3.25 | $ 121.49M |
3/31/2025 | $ 407.91M | 3.93 | $ 103.92M |
12/31/2024 | $ 438.89M | 4.39 | $ 99.98M |
9/30/2024 | $ 432.39M | 4.85 | $ 89.09M |
6/30/2024 | $ 439.18M | 4.68 | $ 93.79M |
3/31/2024 | $ 439.43M | 4.71 | $ 93.34M |
12/31/2023 | $ 432.95M | 4.94 | $ 87.7M |
9/30/2023 | $ 536.57M | 6.32 | $ 84.84M |
6/30/2023 | $ 533.5M | 6.1 | $ 87.4M |
3/31/2023 | $ 533.71M | 5.69 | $ 93.79M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for VANDA PHARMACEUTICALS INC is calculated as follows: AssetsC [ $ 389.53M ] / LiabilitesC [ $ 61.36M ]
(=) Current Ratio [ 6.35 ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |